Dianthus Therapeutics to participate in three investor conferences in September
Dianthus Therapeutics said it will participate in three investor conferences during September, beginning Sept. 2026, as part of its planned investor outreach.
NEW YORK and WALTHAM, Mass., Sept.
01, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc.
NASDAQ:DNTH, a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company’s participation in…